HUP0203831A2 - Kutyaherpeszvírus-fertőzés elleni vakcinák és vakcinázás - Google Patents

Kutyaherpeszvírus-fertőzés elleni vakcinák és vakcinázás

Info

Publication number
HUP0203831A2
HUP0203831A2 HU0203831A HUP0203831A HUP0203831A2 HU P0203831 A2 HUP0203831 A2 HU P0203831A2 HU 0203831 A HU0203831 A HU 0203831A HU P0203831 A HUP0203831 A HU P0203831A HU P0203831 A2 HUP0203831 A2 HU P0203831A2
Authority
HU
Hungary
Prior art keywords
vaccines
vaccine
against canine
canine herpesvirus
herpesvirus infection
Prior art date
Application number
HU0203831A
Other languages
English (en)
Inventor
Hervé Poulet
Original Assignee
Merial
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Merial filed Critical Merial
Publication of HUP0203831A2 publication Critical patent/HUP0203831A2/hu
Publication of HUP0203831A3 publication Critical patent/HUP0203831A3/hu
Publication of HU228703B1 publication Critical patent/HU228703B1/hu

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N7/00—Viruses; Bacteriophages; Compositions thereof; Preparation or purification thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/12—Viral antigens
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/12—Viral antigens
    • A61K39/245—Herpetoviridae, e.g. herpes simplex virus
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/39—Medicinal preparations containing antigens or antibodies characterised by the immunostimulating additives, e.g. chemical adjuvants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/20—Antivirals for DNA viruses
    • A61P31/22—Antivirals for DNA viruses for herpes viruses
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/005—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
    • A61K2039/525—Virus
    • A61K2039/5252—Virus inactivated (killed)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
    • A61K2039/525—Virus
    • A61K2039/5254—Virus avirulent or attenuated
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/545—Medicinal preparations containing antigens or antibodies characterised by the dose, timing or administration schedule
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/55—Medicinal preparations containing antigens or antibodies characterised by the host/recipient, e.g. newborn with maternal antibodies
    • A61K2039/552—Veterinary vaccine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/555—Medicinal preparations containing antigens or antibodies characterised by a specific combination antigen/adjuvant
    • A61K2039/55505—Inorganic adjuvants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/555—Medicinal preparations containing antigens or antibodies characterised by a specific combination antigen/adjuvant
    • A61K2039/55511—Organic adjuvants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/555—Medicinal preparations containing antigens or antibodies characterised by a specific combination antigen/adjuvant
    • A61K2039/55511—Organic adjuvants
    • A61K2039/55566—Emulsions, e.g. Freund's adjuvant, MF59
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/70—Multivalent vaccine
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2710/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA dsDNA viruses
    • C12N2710/00011—Details
    • C12N2710/16011—Herpesviridae
    • C12N2710/16711—Varicellovirus, e.g. human herpesvirus 3, Varicella Zoster, pseudorabies
    • C12N2710/16722—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2710/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA dsDNA viruses
    • C12N2710/00011—Details
    • C12N2710/16011—Herpesviridae
    • C12N2710/16711—Varicellovirus, e.g. human herpesvirus 3, Varicella Zoster, pseudorabies
    • C12N2710/16734—Use of virus or viral component as vaccine, e.g. live-attenuated or inactivated virus, VLP, viral protein
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2710/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA dsDNA viruses
    • C12N2710/00011—Details
    • C12N2710/16011—Herpesviridae
    • C12N2710/16711—Varicellovirus, e.g. human herpesvirus 3, Varicella Zoster, pseudorabies
    • C12N2710/16761—Methods of inactivation or attenuation

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Virology (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Immunology (AREA)
  • Microbiology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Engineering & Computer Science (AREA)
  • Genetics & Genomics (AREA)
  • Epidemiology (AREA)
  • Mycology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Biotechnology (AREA)
  • Molecular Biology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biochemistry (AREA)
  • Communicable Diseases (AREA)
  • Biophysics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Biomedical Technology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Oncology (AREA)
  • General Engineering & Computer Science (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)

Abstract

A találmány tárgyát kutyaherpeszvírus-fertőzés elleni vakcina, annakelőállítására szolgáló eljárások és alkalmazásának módjai képezik,valamint a vakcinát tartalmazó multivalens vakcinacsomag. A találmánytárgyát képező vakcina vemhes szukáknak a vemhesség utolsó harmadábanadva nagy mennyiségű anti-CHV ellenanyag képződését váltja ki a fialásidejére, ami a maternális ellenanyagok által megvédi a kölyköket avírusfertőzéstől. Ó
HU0203831A 2000-01-21 2001-01-19 Vaccination against canine herpesvirus infection and vaccines HU228703B1 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
FR0000797A FR2804026B1 (fr) 2000-01-21 2000-01-21 Vaccination contre l'herpesvirose canine et vaccins
PCT/FR2001/000189 WO2001052887A2 (fr) 2000-01-21 2001-01-19 Vaccination contre l"herpesvirose canine et vaccins

Publications (3)

Publication Number Publication Date
HUP0203831A2 true HUP0203831A2 (hu) 2003-03-28
HUP0203831A3 HUP0203831A3 (en) 2004-07-28
HU228703B1 HU228703B1 (en) 2013-05-28

Family

ID=8846182

Family Applications (1)

Application Number Title Priority Date Filing Date
HU0203831A HU228703B1 (en) 2000-01-21 2001-01-19 Vaccination against canine herpesvirus infection and vaccines

Country Status (13)

Country Link
EP (1) EP1248648B1 (hu)
JP (1) JP2003520249A (hu)
AT (1) ATE540693T1 (hu)
AU (1) AU782657C (hu)
BR (2) BRPI0107771B1 (hu)
CA (1) CA2397861C (hu)
FR (1) FR2804026B1 (hu)
HU (1) HU228703B1 (hu)
MX (1) MXPA02007115A (hu)
NZ (1) NZ520242A (hu)
PL (1) PL209070B1 (hu)
WO (1) WO2001052887A2 (hu)
ZA (1) ZA200205830B (hu)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2006512368A (ja) * 2002-12-19 2006-04-13 アクゾ・ノベル・エヌ・ベー 乳汁を介して母親由来抗体を伝達する三価ワクチン
CN101123982B (zh) * 2005-01-28 2015-06-17 西北大学 脂质和一氧化二氮组合作为用于增强疫苗功效的佐剂

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2909462A (en) 1955-12-08 1959-10-20 Bristol Myers Co Acrylic acid polymer laxative compositions
AU532186B2 (en) 1978-07-21 1983-09-22 Merck & Co., Inc. Herpes virus vaccine
ES2097840T3 (es) * 1987-11-03 1997-04-16 Syntex Inc Adyuvante de vacuna que comprende un tetrapoliol.
US5753235A (en) * 1996-02-15 1998-05-19 Heska Corporation Recombinant canine herpesviruses
JPH11106351A (ja) * 1997-10-02 1999-04-20 Chemo Sero Therapeut Res Inst オイルアジュバントワクチンおよびその製造方法
US6093564A (en) * 1997-10-03 2000-07-25 V.I. Technologies, Inc. Methods and compositions for the selective modification of nucleic acids
GB9726555D0 (en) * 1997-12-16 1998-02-11 Smithkline Beecham Plc Vaccine
FR2775601B1 (fr) * 1998-03-03 2001-09-21 Merial Sas Vaccins vivants recombines et adjuves
FR2776928B1 (fr) * 1998-04-03 2000-06-23 Merial Sas Vaccins adn adjuves

Also Published As

Publication number Publication date
BR0107771A (pt) 2002-11-12
CA2397861A1 (en) 2001-07-26
JP2003520249A (ja) 2003-07-02
AU782657C (en) 2006-07-13
ZA200205830B (en) 2003-09-29
HU228703B1 (en) 2013-05-28
HUP0203831A3 (en) 2004-07-28
EP1248648A2 (fr) 2002-10-16
CA2397861C (en) 2017-04-04
WO2001052887A2 (fr) 2001-07-26
MXPA02007115A (es) 2003-01-28
FR2804026A1 (fr) 2001-07-27
WO2001052887A3 (fr) 2002-01-31
AU3383101A (en) 2001-07-31
AU782657B2 (en) 2005-08-18
PL209070B1 (pl) 2011-07-29
NZ520242A (en) 2004-06-25
BRPI0107771B1 (pt) 2017-06-13
ATE540693T1 (de) 2012-01-15
EP1248648B1 (fr) 2012-01-11
PL356556A1 (en) 2004-06-28
FR2804026B1 (fr) 2004-06-11

Similar Documents

Publication Publication Date Title
IL150602A (en) Proteosome influenza vaccine, method for preparing such and use thereof
EP2601969A3 (en) Norovirus vaccine formulations
BRPI0208301A8 (pt) vacinas de ácido nucléico para prevenção de infecção por flavivírus
EP0755259A4 (en) CHIMERAL cDNA CLONES OF THE VIRUS OF INFECTIOUS BURSAL DISEASE, EXPRESSION PRODUCTS AND Vaccines Based On Them
HUP0202846A2 (hu) Intranazális influenzavírus-oltóanyag
ATE315405T1 (de) Cpg-zusammensetzungen, saponin-adjuvantien und verfahren zu deren verwendung
EP2166019A3 (en) Immunisation against Chlamydia Pneumoniae
DE69918146D1 (de) Verfahren zur therapeutischen impfung
WO2001068129A3 (de) Adjuvans für vakzinen
NO20090178L (no) Vaksiner for malaria
WO2011109511A3 (en) Novel hiv-1 envelope glycoprotein
EP1578766A4 (en) MULTIPURPOSE DNA VACCINES AGAINST HIV-1 PRIMARY GLYCOPROTEIN AND METHODS OF VACCINATION
HUP0302951A2 (hu) Eljárás HBV antigének tisztítására, vakcinákban történő alkalmazásra
HUP0203831A2 (hu) Kutyaherpeszvírus-fertőzés elleni vakcinák és vakcinázás
IL148741A0 (en) Vaccine
EP1667634A4 (en) ANTHRAX VACCINE
MX2009000717A (es) Composicion para vacuna y metodo para inmunizacion.
WO2004083390A3 (en) Virulent systemic feline calicivirus
HUP0202389A2 (hu) Macskafélék calicivírus-betegsége elleni, inaktivált vakcina
DK1227840T3 (da) Adjuverede, genetiske vacciner
Campbell Vaccines for equine influenza
FR2825280B1 (fr) Vaccination contre le virus de l'immunodeficience feline
RU1801212C (ru) Способ отбора детей из группы риска дл ревакцинации против кори
AU2003294192A8 (en) Inclusion bodies as antigens for the oral vaccination of animals
WO2000062803A3 (en) ppGpp AND pppGpp AS IMMUNOMODULATORY AGENTS